WeVote
Log In

Bill

Bill

HB 723

Type 1 Diabetes Early Detection Program

2025 Regular Session Introduced by Robin Bartleman and 7 co-sponsors

Florida establishes statewide Type 1 diabetes early detection screening for newborns and children to identify autoimmune risk markers and enable preventive intervention before disease onset.

Laid on Table, companion bill(s) passed, see CS/CS/HB 958 (Ch. 2025-46)
#subjectindex
0
WeVote Research Nonpartisan
Bill Summary · HB 723

Legislative bill overview

HB 723 establishes a Type 1 Diabetes Early Detection Program in Florida designed to screen newborns and children for Type 1 diabetes risk factors. The bill aims to identify at-risk individuals early so they can receive preventive interventions and medical monitoring before symptom onset.

Why is this important

Type 1 diabetes is an autoimmune condition that can develop rapidly in children, sometimes with life-threatening complications at initial presentation. Early detection of autoimmune markers allows families to monitor for symptoms and seek immediate care if they appear, potentially preventing severe illness. This represents a shift from reactive treatment to proactive screening, which can significantly improve outcomes and quality of life.

Potential points of contention

  • Cost and funding mechanism: Unclear who bears screening program costs and whether insurance will cover testing for asymptomatic individuals
  • Psychological burden: Identifying children as "at-risk" without knowing if they'll develop diabetes could cause parental anxiety and unnecessary medical surveillance
  • Privacy and genetic information: Questions about data handling, long-term storage of genetic/health information, and whether results are reported to insurance companies
  • Scope and equity: Whether program reaches all populations equitably or primarily benefits families with better healthcare access and resources

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.